Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00800228 · ClinicalTrials.gov registry record
Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 96
- Enrollment target
NCT00800228 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 96 participants.
The verdict
NCT00800228 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that blood pressure sensitivity to high sodium intake in healthy humans is characterized by increased urinary excretion of two endogenous sodium pump inhibitors, marinobufagenin (MBG), and ouabain-like compound (OLC). The study also tests the hypothesis that women who breathe slowly and have high resting end tidal CO2 at rest are more likely to have low plasma renin activity and sodium sensitivity of blood pressure than those who breathe more rapidly and maintain lower end tidal CO2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00800228
The ClinicalTrials.gov registry entry for NCT00800228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00800228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00800228 about?
NCT00800228 is a clinical study titled "Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure". The purpose of this study is to test the hypothesis that blood pressure sensitivity to high sodium intake in healthy humans is characterized by increased urinary excretion of two endogenous sodium pump inhibitors, marinobufagenin (MBG), and ouabain-like compound (OLC). The study also tests the hypot...
What is the current status of trial NCT00800228?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2003-03. Estimated completion is 2006-12.
Who is sponsoring clinical trial NCT00800228?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.